Santhera Pharmaceuticals Holding AG SPHDF
$23.25
Last Updated: Apr 28, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
SPHDF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Santhera Pharmaceuticals Holding AG is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Santhera Pharmaceuticals Holding AG. Stock Analysis SPHDF
United States Health Care Micro Cap Santhera Pharmaceuticals Holding AG engages in the development and commercialization of products for the treatment of neuromuscular and pulmonary diseases. The firm operates through one business segment, which is the research, development and commercialization of pharmaceutical products for the treatment of neuromuscular and mitochondrial diseases, such as Duchenne muscular dystrophy (DMD) and cystic fibrosis (CF). The firm focuses also on development of gene therapy for the treatment of LAMA2 (Laminin Subunit Alpha 2) deficient congenital muscular dystrophy (CMD). Santhera operates through its wholly owned subsidiaries: Santhera Pharmaceuticals (Schweiz) AG, Liestal, Santhera Pharmaceuticals (USA) Inc, Santhera Pharmaceuticals (Canada) Inc, Santhera Pharmaceutical (Deutschland) GmbH and Oy Santhera Pharmaceuticals (Finland) Ltd.
Santhera Pharmaceuticals Holding AG (SPHDF) Chart
Financial Metrics & Statements of Santhera Pharmaceuticals Holding AG (SPHDF)
FAQ's for Santhera Pharmaceuticals Holding AG (SPHDF)
- As of August 2026, Santhera Pharmaceuticals Holding AG SPHDF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Santhera Pharmaceuticals Holding AG using these criteria to determine its compliance status.
- Muslim investors may consider investing in Santhera Pharmaceuticals Holding AG if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Santhera Pharmaceuticals Holding AG by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Santhera Pharmaceuticals Holding AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Santhera Pharmaceuticals Holding AG on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Santhera Pharmaceuticals Holding AG (SPHDF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
